Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 8359279)

Published in Eur J Surg Oncol on August 01, 1993

Authors

M Guzzo1, C Grandi, L Licitra, S Podrecca, N Cascinelli, R Molinari

Author Affiliations

1: Division of Head and Neck Surgery, Istituto Nazionale Tumori, Milan, Italy.

Articles by these authors

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45

Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst (2009) 2.83

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71

Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet (1991) 2.58

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst (2001) 2.57

Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness. Tumori (1978) 2.46

Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest (1996) 2.31

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer (1995) 2.28

Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg (2000) 2.27

Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med (1988) 2.15

Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med (2000) 1.93

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial. Ann Oncol (2014) 1.83

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.70

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Results of adjuvant interferon study in WHO melanoma programme. Lancet (1994) 1.62

Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer (1991) 1.58

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Determinants of career structure and advancement among Italian cardiologists. An example of segregation and discrimination against women? SCIC Group. Studio Condizione Italiana Cardiologi. Eur Heart J (1999) 1.56

Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54

Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors. Breast Cancer Res Treat (1999) 1.54

Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg (1991) 1.52

A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52

Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50

Clinical diagnosis and therapy of cutaneous melanoma in situ. Cancer (1996) 1.43

Vitamin supplement use, by demographic characteristics. Am J Epidemiol (1988) 1.42

Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck (1997) 1.33

Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer (1981) 1.33

Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications. Head Neck Surg (1986) 1.33

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study. Oral Oncol (2008) 1.31

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Ann Oncol (2006) 1.29

Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res (1997) 1.29

Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg (1985) 1.27

Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst (1993) 1.23

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study. Clin Cardiol (1997) 1.23

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol (1988) 1.21

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. J Clin Oncol (2001) 1.15

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.14

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06

Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res (1985) 1.06

Prognosis of malignant melanoma according to regional metastases. Am J Roentgenol Radium Ther Nucl Med (1971) 1.06

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05

Malignant lymphomas of Waldeyer's ring: natural history and survival after radiotherapy. Br Med J (1972) 1.03

Cellular and humoral immunity against human malignant melanoma. Int J Cancer (1971) 1.02

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol (2011) 1.02

Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori (1980) 1.01

Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol (1986) 1.01

Psychosocial adjustment of patients surgically treated for head and neck cancer. Head Neck (1992) 0.99

Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98

Selection of a chemically defined medium for submerged cultivation of Streptomyces aureofaciens with high extracellular caseinolytic activity. Biotechnol Bioeng (1977) 0.97

Surgical treatment of primary breast cancer. Schweiz Med Wochenschr (1977) 0.96

Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2013) 0.95

Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95

BANS. A cutaneous region with no prognostic significance in patients with melanoma. Cancer (1986) 0.94

Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer (1991) 0.93

Excision of oral leukoplakias by CO2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori (1986) 0.93

Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol (1996) 0.93

In vivo spectrophotometric evaluation of neoplastic and non-neoplastic skin pigmented lesions--I. Reflectance measurements. Photochem Photobiol (1991) 0.93

Lymphoreticular sarcomas with primary involvement of Waldeyer's ring. Clinical evaluation of 225 cases. Cancer (1970) 0.93

Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer (1994) 0.93

Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer (2001) 0.93

In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2. Int J Cancer (1988) 0.92

Micellar solubilization of biopolymers in organic solvents. Activity and conformation of lysozyme in isooctane reverse micelles. J Biol Chem (1981) 0.91

First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91

Rare cancers of the head and neck area in Europe. Eur J Cancer (2011) 0.91

Oromandibular reconstruction using titanium plate and pectoralis major myocutaneous flap. Acta Otorhinolaryngol Ital (2007) 0.91

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 0.91

Review of 346 patients with free-flap reconstruction following head and neck surgery for neoplasm. J Plast Reconstr Aesthet Surg (2006) 0.90

T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results. Ann Oncol (2011) 0.90

Ultrasonic root-end preparation: influence of cutting angle on the apical seal. J Endod (1998) 0.90

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer (1994) 0.88

Salvage surgery of cervical recurrences after neck dissection or radiotherapy. Head Neck (1993) 0.88

Prognosis of skin melanoma with regional node metastases (stage II). J Surg Oncol (1984) 0.88

Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women. Hypertension (1999) 0.88

Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int J Oncol (1999) 0.87

Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol (1982) 0.87

Adenocarcinoma of ethmoid sinus: an occupational disease. Acta Otorhinolaryngol Ital (2004) 0.87

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Ann Oncol (2003) 0.87

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. Cancer Immunol Immunother (1986) 0.87

Retrospective comparison of conservative and radical neck dissection in laryngeal cancer. Ann Otol Rhinol Laryngol (1981) 0.87

Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg (1990) 0.86